Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina
- PMID: 1749203
- DOI: 10.1007/BF01649425
Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina
Abstract
The effects of atenolol, nifedipine, and their combination on gas exchange and exercise tolerance were studied in 27 patients with effort angina and normal global ventricular function in an open-label and randomized cross-over trial. Symptom-limited semi-supine exercise tests using a ramp protocol (20 W/min) with simultaneous breath-by-breath analysis of gas exchange were carried out after a 4-day wash-out period and after consecutive 2-week treatment periods with atenolol (50 mg b.i.d.), slow-release nifedipine (20 mg b.i.d.), and their combination (b.i.d.). Exercise tolerance was not significantly higher with atenolol than with nifedipine [118(24) vs 113(23) W]. Combination therapy [120(23) W] was more effective than monotherapy with nifedipine (p less than 0.05) but produced no further increase in exercise tolerance over atenolol monotherapy. Maximum oxygen uptake was not significantly different among the treatments. In the range of light to moderate exercise, the slope of the VO2-workload regression line expressed as ml.min-1.W-1 was lower with atenolol than with nifedipine [8.64(1.59) vs 10.28(1.74), p less than 0.005] and intermediate with combination therapy [9.99(1.83)]. The intercept on the VO2 axis was higher with atenolol than with nifedipine [366(111) vs 299(113) ml.min-1, p less than 0.05]. A similar pattern of results was seen when the drug effects on the slope of the VCO2-workload relation were analyzed. VE was higher with nifedipine than with atenolol at all points of the regression analysis [greater than 30 W].(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effects of antianginal therapy with atenolol and slow-release nifedipine on respiratory gas exchange and on the ventilatory requirements for aerobic exercise.Z Kardiol. 1994;83 Suppl 3:83-7. Z Kardiol. 1994. PMID: 7941677 Clinical Trial.
-
Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris.Eur Heart J. 1993 Oct;14(10):1369-74. doi: 10.1093/eurheartj/14.10.1369. Eur Heart J. 1993. PMID: 8262084 Clinical Trial.
-
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.Cardiovasc Drugs Ther. 1993 Dec;7(6):909-13. doi: 10.1007/BF00877726. Cardiovasc Drugs Ther. 1993. PMID: 8011570 Clinical Trial.
-
The combination of slow-release nifedipine and atenolol for stable angina.Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:899-904. doi: 10.1007/BF02018289. Cardiovasc Drugs Ther. 1990. PMID: 2076397 Review.
-
[Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].Minerva Cardioangiol. 1993 Sep;41(9):349-63. Minerva Cardioangiol. 1993. PMID: 7903118 Review. Italian.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous